trial

Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills

NCTId NCT00223418
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 43 (actual)
Sponsored by The University of Texas Health Science Center at San Antonio
Primary completion 2007-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
43 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2004-01
Primary completion
2007-06
Eligibility
ALL · 18 Years · 52 Years

Interventions & indications

Drugs
Aripiprazole

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor
Bristol-MyersCollaborator

Investigators

2
Dawn' I Velligan, Ph.D.Principal Investigator
Mary D. Woolsey, M.S.Study Director

Sites

1 total
San Antonio, United States

Facts & assertions

4 sourced
Enrollment
43
Phase
NA
Primary Completion Date
2007-06
Status
COMPLETED
relationships
The graph out of here
drug
Aripiprazole
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
collaborator
Bristol-Myers
company
indication
Schizoaffective Disorder
indication
Schizophenia Disorder
indication
Psychotic Disorders
indication
investigator
Dawn' I Velligan, Ph.D.
person
Mary D. Woolsey, M.S.
person